IL156041A0 - Nucleic acid adjuvants - Google Patents
Nucleic acid adjuvantsInfo
- Publication number
- IL156041A0 IL156041A0 IL15604101A IL15604101A IL156041A0 IL 156041 A0 IL156041 A0 IL 156041A0 IL 15604101 A IL15604101 A IL 15604101A IL 15604101 A IL15604101 A IL 15604101A IL 156041 A0 IL156041 A0 IL 156041A0
- Authority
- IL
- Israel
- Prior art keywords
- nucleic acid
- molecules
- truncated
- acid adjuvants
- coding region
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72431500A | 2000-11-27 | 2000-11-27 | |
PCT/US2001/043151 WO2003004055A2 (en) | 2000-11-27 | 2001-11-26 | Nucleic acid adjuvants |
Publications (1)
Publication Number | Publication Date |
---|---|
IL156041A0 true IL156041A0 (en) | 2003-12-23 |
Family
ID=24909936
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15604101A IL156041A0 (en) | 2000-11-27 | 2001-11-26 | Nucleic acid adjuvants |
IL156041A IL156041A (en) | 2000-11-27 | 2003-05-21 | An auxiliary drug preparation that includes nucleic acid sequences |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL156041A IL156041A (en) | 2000-11-27 | 2003-05-21 | An auxiliary drug preparation that includes nucleic acid sequences |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1379273B1 (de) |
JP (1) | JP4221289B2 (de) |
KR (1) | KR20040045391A (de) |
CN (1) | CN1317034C (de) |
AT (1) | ATE442858T1 (de) |
AU (1) | AU2001297988B2 (de) |
BR (1) | BR0115646A (de) |
CA (1) | CA2429708A1 (de) |
DE (1) | DE60139959D1 (de) |
DK (1) | DK1379273T3 (de) |
ES (1) | ES2332261T3 (de) |
IL (2) | IL156041A0 (de) |
MX (1) | MXPA03004638A (de) |
NZ (1) | NZ526175A (de) |
PT (1) | PT1379273E (de) |
WO (1) | WO2003004055A2 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG147430A1 (en) | 2003-10-10 | 2008-11-28 | Powderject Vaccines Inc | Nucleic acid constructs |
WO2005077977A2 (en) | 2004-02-11 | 2005-08-25 | Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa | Carcinoembryonic antigen fusions proteins and uses thereof |
GB0507997D0 (en) * | 2005-02-01 | 2005-05-25 | Powderject Vaccines Inc | Nucleic acid constructs |
JP5311508B2 (ja) * | 2008-05-07 | 2013-10-09 | 国立大学法人大阪大学 | 非共有結合型コラーゲン架橋剤 |
KR101881176B1 (ko) | 2010-09-15 | 2018-07-23 | 랜달 제이 미스니 | 박테리아 독소에서 유래된 수송 서열을 이용한 생물활성제 시스템 및 방법 |
US11246915B2 (en) | 2010-09-15 | 2022-02-15 | Applied Molecular Transport Inc. | Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo |
CN103060253A (zh) * | 2013-01-24 | 2013-04-24 | 麻丽丹 | 霍乱弧菌ctxAB基因的质粒克隆菌株以及制备方法和应用 |
RU2723178C2 (ru) | 2014-05-07 | 2020-06-09 | ЭППЛАЙД МОЛЕКЬЮЛАР ТРАНСПОРТ ЭлЭлСи | Слитые молекулы, происходящие от Cholix-токсина, для пероральной доставки биологически активных нагрузок |
EP4082558B1 (de) | 2018-03-08 | 2023-08-23 | Applied Molecular Transport Inc. | Von toxinen abgeleitete konstrukte zur oralen verabreichung |
EP4083058A3 (de) | 2018-11-07 | 2023-01-11 | Applied Molecular Transport Inc. | Verabreichungskonstrukte für die transzytose und zugehörige verfahren |
TW202120521A (zh) | 2019-08-16 | 2021-06-01 | 美商應用分子運輸公司 | 組合物、配方及介白素生產及純化 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5219740A (en) | 1987-02-13 | 1993-06-15 | Fred Hutchinson Cancer Research Center | Retroviral gene transfer into diploid fibroblasts for gene therapy |
TW404844B (en) | 1993-04-08 | 2000-09-11 | Oxford Biosciences Ltd | Needleless syringe |
GB9416663D0 (en) | 1994-08-17 | 1994-10-12 | Oxford Bioscience Limited | Particle delivery |
AU3703895A (en) | 1994-10-24 | 1996-05-15 | Oxford Biosciences Limited | Particle delivery |
GB9426379D0 (en) | 1994-12-23 | 1995-03-01 | Oxford Biosciences Ltd | Particle delivery |
US6056960A (en) * | 1995-06-07 | 2000-05-02 | Kaslow; Harvey R. | Compositions exhibiting ADP-ribosyltransferase activity and methods for the preparation and use thereof |
GB9612629D0 (en) | 1996-06-17 | 1996-08-21 | Oxford Biosciences Ltd | Method for providing dense particle compositions for use in transdermal particle delivery |
US5980898A (en) | 1996-11-14 | 1999-11-09 | The United States Of America As Represented By The U.S. Army Medical Research & Material Command | Adjuvant for transcutaneous immunization |
-
2001
- 2001-11-26 WO PCT/US2001/043151 patent/WO2003004055A2/en active Search and Examination
- 2001-11-26 CA CA002429708A patent/CA2429708A1/en not_active Abandoned
- 2001-11-26 IL IL15604101A patent/IL156041A0/xx unknown
- 2001-11-26 ES ES01274277T patent/ES2332261T3/es not_active Expired - Lifetime
- 2001-11-26 AT AT01274277T patent/ATE442858T1/de active
- 2001-11-26 PT PT01274277T patent/PT1379273E/pt unknown
- 2001-11-26 DK DK01274277T patent/DK1379273T3/da active
- 2001-11-26 BR BR0115646-2A patent/BR0115646A/pt not_active Application Discontinuation
- 2001-11-26 EP EP01274277A patent/EP1379273B1/de not_active Expired - Lifetime
- 2001-11-26 JP JP2003510065A patent/JP4221289B2/ja not_active Expired - Fee Related
- 2001-11-26 MX MXPA03004638A patent/MXPA03004638A/es active IP Right Grant
- 2001-11-26 AU AU2001297988A patent/AU2001297988B2/en not_active Ceased
- 2001-11-26 CN CNB018195709A patent/CN1317034C/zh not_active Expired - Fee Related
- 2001-11-26 KR KR10-2003-7007121A patent/KR20040045391A/ko active Search and Examination
- 2001-11-26 DE DE60139959T patent/DE60139959D1/de not_active Expired - Lifetime
- 2001-11-26 NZ NZ526175A patent/NZ526175A/en unknown
-
2003
- 2003-05-21 IL IL156041A patent/IL156041A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR20040045391A (ko) | 2004-06-01 |
EP1379273A2 (de) | 2004-01-14 |
ATE442858T1 (de) | 2009-10-15 |
PT1379273E (pt) | 2009-11-27 |
DK1379273T3 (da) | 2009-11-09 |
JP4221289B2 (ja) | 2009-02-12 |
CA2429708A1 (en) | 2003-01-16 |
WO2003004055A2 (en) | 2003-01-16 |
EP1379273B1 (de) | 2009-09-16 |
CN1317034C (zh) | 2007-05-23 |
CN1537013A (zh) | 2004-10-13 |
IL156041A (en) | 2010-05-17 |
DE60139959D1 (de) | 2009-10-29 |
BR0115646A (pt) | 2005-12-13 |
NZ526175A (en) | 2006-01-27 |
MXPA03004638A (es) | 2004-04-20 |
JP2004536107A (ja) | 2004-12-02 |
ES2332261T3 (es) | 2010-02-01 |
AU2001297988B2 (en) | 2006-10-26 |
WO2003004055A3 (en) | 2003-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4078599A (en) | Expression vectors for stimulating an immune response and methods of using the same | |
GB2347932B (en) | Vectors for the delivery of 5T4 antigen | |
BR9906927A (pt) | Proteìnas de neisseria meningitidis | |
BR0010361A (pt) | Seq ências genÈmicas de neisseria e uso destas | |
PT100781A (pt) | Sequencias de dna codificadoras de proteinas de superficie externa, proteinas contendo as referidas sequencias, obtidas a partir de borrelia burgdorferi, e vacinas contendo as referidas proteinas | |
NZ540544A (en) | Nucleic acids and proteins from streptococcus groups A & B | |
PT1487485E (pt) | Adjuvantes de imidazoquinolina para vacinas de adn | |
WO2001035991A3 (en) | Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof | |
EP1288299A3 (de) | TRNA Synthetase | |
NZ532665A (en) | Neisseria meningitidis antigens and compositions | |
EP1187591A4 (de) | Mit entzündlichen darmerkrankungen (ibd) assoziierte mikrobielle antigene und verfahren derer anwendung | |
AU7235794A (en) | Vaccine compositions | |
IL156041A0 (en) | Nucleic acid adjuvants | |
WO2002062296A3 (en) | Methods and compositions useful for stimulating an immune response | |
WO2003085085A3 (en) | Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen | |
AU8127494A (en) | Chimeric proteins comprising borrelia polypeptides: uses therefor | |
DK1379550T3 (da) | Et kimært protein omfattende non-toxisk pseudomonas exotoxin A og en type IV pilin sekvenser | |
MXPA01008605A (es) | Proteina de enlace del antigeno goodpasture. | |
DK0811071T3 (da) | Amplifikeringssekvenser hidrørende fra desmin-genet, vektorer indeholdende disse sekvenser og anvendelse heraf til fremstilling af proteiner | |
AU2001248822A1 (en) | Gd3-mimetic peptides | |
EP0972054A4 (de) | Steigerung der immunantwort unter verwendung von zielgerichteten molekülen | |
WO2000063385A3 (en) | Nucleic acid immunization | |
HK1011924A1 (en) | Monoclonal antibodies to antigens expressed by hematopoietic facilitaroy cells. | |
WO2000047227A3 (en) | Mycobacterium tuberculosis, immunization | |
MXPA03010527A (es) | Composicion de vacuna. |